Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–22 of 22 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: taVNS 30 minutes Clear all

Conditions: Healthy
Interventions: transcutaneous auricular vagus nerve stimulation 30/30, transcutaneous auricular vagus nerve stimulation 10/10; Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 80 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Anxiety, Distress, Emotional, Effects of Vibration, Healthy
Interventions: Neuvana 2.0 Transcutaneous Auricular Vagal Nerve Stimulation (TaVNS), Waitlist Control, Healthy Controls: Substudy Group III, Distressed Workers: Subgroup II; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 21 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypoxia-Ischemia, Brain
Interventions: taVNS; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 7 Years to 18 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Fibromyalgia (FM), Posttraumatic Stress Disorder (PTSD)
Interventions: tAN plus PEPC, sham plus PEPC; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Pain, Chronic, Irritable Bowel Syndrome, Symptom Cluster
Interventions: Home-based taVNS intervention; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 29 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Stroke
Interventions: transcutaneous auricular vagus nerve stimulation (taVNS); Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 13 Years to 21 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Learning, taVNS
Interventions: transcutaneous auricular vagus nerve stimulation (taVNS) 15 minutes, taVNS 30 minutes, taVNS 45 minutes, taVNS 60 minutes, taVNS 75 minutes, taVNS 0 minutes; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Delirium
Interventions: Transauricular Vagus Nerve Stimulation; Device
Lead sponsor: Stony Brook University; Other
Eligibility: 22 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Hemostasis, Blood Biomarkers
Interventions: Volta System; Device
Lead sponsor: Spark Biomedical, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Anorexia Nervosa
Interventions: taVNS, Sham; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 14 Years to 22 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimer Disease, Aging
Interventions: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS); Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Heavy Drinking
Interventions: Active RAVANS, Brief Mindfulness-Based Intervention; Device · Behavioral
Lead sponsor: Cambridge Health Alliance; Other
Eligibility: 21 Years to 29 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Malden, Massachusetts

Conditions: PARKINSON DISEASE (Disorder)
Interventions: transcutaneous auricular vagus nerve stimulation; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Depression
Interventions: Vagus Nerve Stimulation, Transcranial Magnetic Stimulation; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Depression, Anxiety
Interventions: transcutaneous auricular neurostimulation; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Knee Osteoarthritis
Interventions: Methylprednisolone acetate, taVNS; Drug · Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 45 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Diabetes Mellitus, Type 2, Obesity
Interventions: taVNS, Sham taVNS; Device
Lead sponsor: Burrell College of Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Las Cruces, New Mexico

Conditions: Inflammation
Interventions: Occipito-Atlantal Decompression (OA DC), Sham Occipito-Atlantal Decompression (Sham OA DC), Splenic Lymphatic Pump Technique (SpLPT), Sham Splenic Lymphatic Pump Technique (Sham SpLPT), Transcutaneous Auricular Vagus Nerve Stimulation (taVNS), Sham Transcutaneous Auricular Vagus Nerve Stimulation (Sham taVNS); Procedure · Device
Lead sponsor: Burrell College of Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Las Cruces, New Mexico

Conditions: No Condition
Interventions: taVNS, Mindfulness Meditation, low intensity taVNS; Device · Behavioral · Other
Lead sponsor: University of Houston; Other
Eligibility: 18 Years to 29 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Psychosocial Well-being, Neurocognitive Function, Cognitive Complaint, Cognitive Dysfunction
Interventions: taVNS, Computerized Cognitive Training; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 45 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Atrial Fibrillation, Persistent
Interventions: active taVNS, sham-taVNS; Device
Lead sponsor: Burrell College of Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Las Cruces, New Mexico

Conditions: Breast Cancer Survivors
Interventions: Active taVNS, Sham taVNS; Device
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 79 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Tallahassee, Florida

Search by objective public record fields.

Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1

Effect of (TaVNS) on Anxiety and Brain Function in Distressed Health Care Workers

Transauricular Vagus Nerve Stimulation in Children

Treatment of Fibromyalgia and PTSD With Live and Inactive Vagus Nerve Stimulation With PEPC

Home-based Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for IBS Pain

Tolerability of Transcutaneous Vagal Nerve Stimulation

Learning and Ear Stimulation

TaVNS for Delirium

Delivering Transcutaneous Auricular Neurostimulation to Regulate Platelet Activity in Healthy Human Subjects

Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders

Vagus Nerve Stimulation to Enhance Memory in Aging

Exploring the Effects of Brief Mindfulness Training With Vagal Nerve Stimulation on Alcohol Cue Reactivity Among Young Adult Heavy Drinkers

Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease

taVNS or TMS or Both for Depression

taVNS on the Inpatient Psychiatric Unit

taVNS in Veterans With Knee OA (AVAHCS)

Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Obesity and Insulin Resistance

Anti-inflammatory Actions of Osteopathic Manipulative Treatment

Stimulating Your Nervous System for Calm (SYNC) Study

taVNS + CCT for Neurocognitive Rehab

Effect of taVNS on Heart Rate in Persistent Atrial Fibrillation

taVNS for Breast Cancer Pain and Symptom Management